Clinical Trials Logo

Myocardium; Injury clinical trials

View clinical trials related to Myocardium; Injury.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06211244 Not yet recruiting - Clinical trials for Coronary Artery Disease

Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients

Start date: May 1, 2024
Phase:
Study type: Observational

Background: Cardiovascular disease (CVD) is one of the leading causes of morbidity and mortality among dialysis patients. Eotaxin-1(also known as Eotaxin and CCL11), an eosinophil-specific chemoattractant that plays a role in a variety of pathologic conditions including allergy, coronary heart disease, and inflammatory bowel disease. CCL11 has been shown to be overexpressed in human atherosclerotic lesions. Moreover, eotaxin-1 levels are higher in non-uremic coronary artery disease patients than in healthy individuals. Methods: The study will enrolled 400 hemodialysis patients. Patients are diagnosed with coronary artery disease based on clinical presentation and confirmed by angiography. Serum eotaxin-1 and 8-isoprostane levels are determined by enzyme-linked immunosorbent assay (ELISA). High-sensitivity cTnI immunoassays and albumin redox state by high-performance liquid chromatography are used for measurements. Aim: In this study, we aimed to determine the eotaxin-1 concentrations of patients with coronary artery disease and to investigate the role of eotaxin-1 and markers of myocardial injury.